• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[光化性角化病患者对所接受护理的认知]

[The perception of care received by patients with actinic keratosis].

作者信息

Salido-Vallejo R, González-Velasco M, Guilabert M, García E I, Mira J J

机构信息

Hospital Reina Sofía de Córdoba, Córdoba, España.

Vocalía de Dermofarmacia del Colegio Oficial de Farmacéuticos de Sevilla, Sevilla, España.

出版信息

J Healthc Qual Res. 2018 Nov-Dec;33(6):360-369. doi: 10.1016/j.jhqr.2018.09.005. Epub 2018 Nov 27.

DOI:10.1016/j.jhqr.2018.09.005
PMID:30497970
Abstract

OBJECTIVE

To analyse barriers limiting an integral approach in the care process of patients with actinic keratosis, and to validate a questionnaire of their perception in order to assess this approach.

METHOD

A qualitative study (Focus Group) was conducted to assess the perception of the healthcare process of professionals (dermatologists, family doctors, nurses, pharmacists and managers), and patients. A validation study of a new tool was conducted, defining the scope and contents of a questionnaire of perceived quality. Reliability, consistency and validity were analysed after inviting a convenience sample of 225 patients to respond.

RESULTS

Underdiagnosis in primary care, a higher variability in resources, and access to the health care circuit, together with gaps in patient information about actinic keratosis, are relevant barriers to achieve comprehensive care in this disease condition. The result of the focus groups advised to elaborate 14 reactive items. A total of 224 patients responded (mean age 71.6, SD 11.1), of which 153 (68%) were men. Two factors were isolated including 12 items (explained variance of 58%). The consistency of this factorial solution was .87, the split-half reliability being .76, with the scores in the factors showing an adequate predictive capacity.

CONCLUSIONS

The coordination between levels and to reduce to variability in equipment and clinical decision making in Primary Care are the most prominent barriers. The questionnaire has appropriate metric properties and it explores the information and care by the medical staff and the information and advice provided by the pharmacist.

摘要

目的

分析限制光化性角化病患者护理过程中采用综合方法的障碍,并验证一份关于他们认知的问卷,以评估这种方法。

方法

进行了一项定性研究(焦点小组),以评估专业人员(皮肤科医生、家庭医生、护士、药剂师和管理人员)以及患者对医疗过程的认知。对一种新工具进行了验证研究,确定了一份感知质量问卷的范围和内容。在邀请225名方便样本患者进行回答后,分析了可靠性、一致性和有效性。

结果

初级保健中的诊断不足、资源的较大差异以及进入医疗保健流程的机会,再加上患者关于光化性角化病的信息存在差距,是在这种疾病情况下实现全面护理的相关障碍。焦点小组的结果建议拟定14个反应性项目。共有224名患者做出回应(平均年龄71.6岁,标准差11.1),其中153名(68%)为男性。分离出两个因素,包括12个项目(解释方差为58%)。这个因子解的一致性为0.87,分半信度为0.76,各因素得分显示出足够的预测能力。

结论

各级之间的协调以及减少初级保健中设备和临床决策的差异是最突出的障碍。该问卷具有适当的度量特性,它探讨了医务人员提供的信息和护理以及药剂师提供的信息和建议。

相似文献

1
[The perception of care received by patients with actinic keratosis].[光化性角化病患者对所接受护理的认知]
J Healthc Qual Res. 2018 Nov-Dec;33(6):360-369. doi: 10.1016/j.jhqr.2018.09.005. Epub 2018 Nov 27.
2
Adaptation and validation of the Spanish version of the Actinic Keratosis Quality of Life questionnaire.《光化性角化病生活质量问卷》西班牙语版本的改编与验证
Actas Dermosifiliogr. 2016 Jul-Aug;107(6):474-81. doi: 10.1016/j.ad.2016.03.003. Epub 2016 Apr 12.
3
Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.光化性角化病管理的洞察:全科医生和皮肤科医生的定性访谈研究。
Br J Dermatol. 2019 Jul;181(1):96-104. doi: 10.1111/bjd.17818. Epub 2019 Mar 15.
4
Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis.《光化性角化病评估与治疗欧洲指南》的西班牙文改编版
Actas Dermosifiliogr. 2014 May;105(4):378-93. doi: 10.1016/j.adengl.2013.11.004. Epub 2014 Apr 13.
5
Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire.《光化性角化病生活质量问卷》瑞士(德语)版。
Dermatology. 2018;234(1-2):51-59. doi: 10.1159/000488053. Epub 2018 Apr 18.
6
[Actinic keratosis: New concept and therapeutic update].[光化性角化病:新概念与治疗进展]
Aten Primaria. 2017 Oct;49(8):492-497. doi: 10.1016/j.aprim.2017.01.004. Epub 2017 Apr 17.
7
Validity and Reliability of the Dutch Adaptation of the Actinic Keratosis Quality of Life Questionnaire (AKQoL).荷兰语版光化性角化病生活质量问卷(AKQoL)的有效性和可靠性。
Dermatology. 2018;234(1-2):60-65. doi: 10.1159/000489118. Epub 2018 Jun 15.
8
The value of the histopathologic examination in the diagnosis and management of the actinic keratosis.组织病理学检查在光化性角化病诊断和治疗中的价值。
Rom J Morphol Embryol. 2012;53(4):927-34.
9
Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit.美国光化性角化病治疗实践趋势:尽管有获益证据,但 0.5%氟尿嘧啶和联合冷冻疗法加氟尿嘧啶的使用率较低。
J Cutan Med Surg. 2012 Mar-Apr;16(2):107-14. doi: 10.2310/7150.2011.11002.
10
Managing actinic keratosis in primary care.基层医疗中光化性角化病的管理
Practitioner. 2016 Oct;260(1797):25-9.

引用本文的文献

1
Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.光化性角化病局部治疗的患者报告结局:系统评价。
Dermatol Ther. 2021 Mar;34(2):e14833. doi: 10.1111/dth.14833. Epub 2021 Feb 21.